Go Ad-Free
    My Alerts
    Moneycontrol
    Moneycontrol PRO
    HomeNewsCipla

    Stock analysis is used by traders to make buy and sell call. It’s an approach to make informed decisions while investing in stocks. Stock analysis can be categorised into – fundamental analysis and technical analysis. Fundamental analysis is evaluation of data from sources, including financial records, economic reports, company assets, and market share. Analysts typically study the company’s financial statements – balance sheet, income statement, cash flow statement, and footnotes. These statements are made available to the investors in the form of quarterly earnings, disclosures to stock exchanges in compliance with the Securities and Exchange Board of India (Sebi) norms. In fundamental analysis, the analysts particularly check for a company's core income, income from other sources, profitability, guidance, assets and liabilities and debt ratio among other parameters. The other method, i.e. the technical analysis focuses purely on statistical data. It works on two assumptions; one, the stock price reflects the fundamentals. Second, the study of past and present movement in prices can help determine the future price trends. Technical analysis primarily deals with price, volume, demand and supply factors. This method is effective only when supply and demand forces influence the market. However, when outside factors are involved in a price movement, technical analysis may not be successful. More

    Jump to

    • Sell DLF, Tata Motors, PNB: Aashish Tater

      In CNBC-TV18's popular show Bull's Eye, Aashish Tater of FortuneWizard.com shares trading strategy of the day.

    • Aashish Tater bullish on pharma sectors for long-term

      In an interview to CNBC-TV 18 Aashish Tater, Head of Research, Fortunewizard.com is bullish on Pharma sector. He discusses Glenmark and Cipla which are a buy for atleast a period of 12-18 months.

    • Cipla has target of Rs 730: Aashish Tater

      Cipla has target of Rs 730, says Aashish Tater, Head of Research, Fortunewizard.com. The year-on-year performance has been staggering and the momentum is going to continue even going forward in terms of EPS as well as top-line growth.

    • Bull's Eye: Buy MCX, Cipla, Dhanlaxmi Bank, Short DLF

      Bull's Eye, CNBC-TV18's popular game show, where market experts come together to dish out trading strategies for you to make your week more exciting and compete with each other to see whose portfolio is the strongest.

    • Buy IRB Infra, United Spirits, Cipla: Aashish Tater

      In CNBC-TV18's popular show Bull's Eye, Aashish Tater of FortuneWizard.com shares trading strategy of the day.

    • Bull's eye: Buy IRB Infra, Noida Toll short India Cements

      Bull's Eye, CNBC-TV18's popular game show, where market experts come together to dish out trading strategies for you to make your week more exciting and compete with each other to see whose portfolio is the strongest.

    • Accumulate Dr Reddys, Cipla on dip: Karun Mutha

      Accumulate Dr Reddys Laboratories and Cipla on dip, says Karun Mutha, HSBC Invest Direct.

    • Cipla may rally to Rs 440, says SP Tulsian

      Cipla may rally to Rs 440, says SP Tulsian, sptulsian.com.

    • Remain invested in Cipla, says Rajesh Agarwal

      Remain invested in Cipla, says Rajesh Agarwal, Eastern Financiers. The company is on aright growth path, the margins have shown marked improvement. With no major capex in the near future, the performance is going to continue.

    • Expect 8-10% rally in Cipla, says Mohindar

      Rahul Mohindar of viratechindia.com is of the view that, Cipla may rally by 8-10% in coming days.

    • Cipla can touch Rs 500: Sudarshan Sukhani

      Cipla can touch Rs 500, says Sudarshan Sukhani of s2analytics.com.

    • Buy Cipla on dips to Rs 375; SL Rs 368: Harchekar

      One can buy Cipla on dips towards Rs 375 with a stoploss of Rs 368 for the target of Rs 420, says Amit Harchekar of IIFL.

    • Buy Cipla, says Sudarshan Sukhani

      Buy Cipla, says Sudarshan Sukhani of s2analytics.com.

    • Buy Cipla, says Sudarshan Sukhani

      One can buy Cipla, says Sudarshan Sukhani of s2analytics.com. It has gone through a deep correction, from Rs 390-350; that Rs 350 level is holding. It also offers a strong support level, because earlier Rs 350 was support.

    • ONGC has target of Rs 350: Sukhani

      ONGC has target of Rs 350, says Sudarshan Sukhani of s2analytics.com.

    • Cipla can see sustained uptrend: Sukhani

      Sudarshan Sukhani of s2analytics.com is of the view that Cipla can see sustained uptrend.

    • Avoid Siemens, says Sudarshan Sukhani

      Avoid Siemens, says Sudarshan Sukhani of s2analytics.com.

    • Two pharma stocks that can improve health of your portfolio

      Ranbaxy and Cipla were at 52 week highs on Monday. Kour expects Cipla to perform well going ahead. She is bullish on this stock; however, she is cautious on Ranbaxy.

    • Check out: Darashaw's stock picks and wealth creators

      Regan F Homavazir continues to remain bullish on HDFC Bank because the longer term picture is extremely positive. He also likes J&K Bank.

    • Cipla can touch Rs 430-440: Ambareesh Baliga

      Cipla can touch Rs 430-440, says Ambareesh Baliga, Market Analyst.

    • Enter Cipla at Rs 365, says Amit Gupta

      One can enter Cipla at Rs 365 and on the higher side we look Rs 390 levels. On the downside one can keep a stop loss at Rs 355, says Amit Gupta, ICICI Direct.

    • Drug makers in India to sustain 'premium' valuations: HSBC

      HSBC raises target prices for some Indian drug makers saying "robust" earnings will help sustain the "premium" valuations in the sector.

    • ICICI Bank can test Rs 1000: Sudarshan Sukhani

      Sudarshan Sukhani of s2analytics.com is of the view that ICICI Bank should be good for Rs 1,000 if the Nifty starts its rally again. It is in a small trading range and this time it should breakout.

    • Zee Entertainment has target of Rs 200: Salil Sharma

      Salil Sharma, Technical Analyst, Kapur Sharma & Co is of the view that Zee Entertainment Enterprises has target of Rs 200.

    • Cipla may go around Rs 365-370 levels: Sekhar

      Phani Sekhar of Angel Broking is of the view Cipla may go around Rs 365-370 levels.

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347